Search by Drug Name or NDC
NDC 45802-0060-70 Bacitracin 500 [USP'U]/g Details
Bacitracin 500 [USP'U]/g
Bacitracin is a TOPICAL OINTMENT in the HUMAN OTC DRUG category. It is labeled and distributed by Padagis Israel Pharmaceuticals Ltd. The primary component is BACITRACIN.
MedlinePlus Drug Summary
Bacitracin is used to help prevent minor skin injuries such as cuts, scrapes, and burns from becoming infected. Bacitracin is in a class of medications called antibiotics. Bacitracin works by stopping the growth of bacteria.
Related Packages: 45802-0060-70Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Bacitracin Topical
Product Information
NDC | 45802-0060 |
---|---|
Product ID | 45802-060_bba42abe-613c-4d5b-9eee-bb73e8ca6674 |
Associated GPIs | 90100010004210 |
GCN Sequence Number | 030027 |
GCN Sequence Number Description | bacitracin PACKET 500 UNIT/G TOPICAL |
HIC3 | Q5W |
HIC3 Description | TOPICAL ANTIBIOTICS |
GCN | 31811 |
HICL Sequence Number | 004047 |
HICL Sequence Number Description | BACITRACIN |
Brand/Generic | Generic |
Proprietary Name | Bacitracin |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Bacitracin |
Product Type | HUMAN OTC DRUG |
Dosage Form | OINTMENT |
Route | TOPICAL |
Active Ingredient Strength | 500 |
Active Ingredient Units | [USP'U]/g |
Substance Name | BACITRACIN |
Labeler Name | Padagis Israel Pharmaceuticals Ltd |
Pharmaceutical Class | Decreased Cell Wall Synthesis & Repair [PE] |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part333B |
Listing Certified Through | 2024-12-31 |
Package
Package Images


NDC 45802-0060-70 (45802006070)
NDC Package Code | 45802-060-70 |
---|---|
Billing NDC | 45802006070 |
Package | 144 PACKET in 1 CARTON (45802-060-70) / .9 g in 1 PACKET |
Marketing Start Date | 2011-06-20 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL bebbedf6-dd65-47a4-aa3e-ad197b3e05a1 Details
Warnings
Directions
INGREDIENTS AND APPEARANCE
BACITRACIN
bacitracin ointment |
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
Labeler - Padagis Israel Pharmaceuticals Ltd (600093611) |
Revised: 11/2021
Document Id: bba42abe-613c-4d5b-9eee-bb73e8ca6674
Set id: bebbedf6-dd65-47a4-aa3e-ad197b3e05a1
Version: 6
Effective Time: 20211110